Byoung D. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
LRRK2 controls COX assembly through regulation of redox status of mitochondrial copper chaperones.
Journal: Redox biology
Published: December 24, 2025
Current therapeutic strategies in Parkinson's disease: Future perspectives.
Journal: Molecules and cells
Published: May 29, 2025
Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease.
Journal: Molecular neurodegeneration
Published: October 20, 2024
Neuroprotective effect of L-DOPA-induced interleukin-13 on striatonigral degeneration in cerebral ischemia.
Journal: Cell death & disease
Published: April 03, 2024
Suppression of Glioblastoma Stem Cell Potency and Tumor Growth via LRRK2 Inhibition.
Journal: International journal of stem cells
Published: March 22, 2024
LC3B drives transcription-associated homologous recombination via direct interaction with R-loops.
Journal: Nucleic acids research
Published: November 09, 2023
Modified Protocol to Enable the Study of Hemorrhage and Hematoma in a Traumatic Brain Injury Mouse Model.
Journal: Frontiers in neurology
Published: June 04, 2021
High-Performance Conducting Polymer Nanotube-based Liquid-Ion Gated Field-Effect Transistor Aptasensor for Dopamine Exocytosis.
Journal: Scientific reports
Published: September 24, 2019
LRRK2 and membrane trafficking: nexus of Parkinson's disease.
Journal: BMB reports
Published: June 27, 2019
Last Updated: 09/26/2026